Homeopathy 2020; 109(04): 189-190
DOI: 10.1055/s-0040-1718742
Editorial

Bigger and Better

Robert T. Mathie
1  Acting Editor, Homeopathy
› Author Affiliations

In a year that, to quote New Zealand's Prime Minister, Jacinda Ardern, ‘has frankly been terrible’ for the world,[1] it is a pleasant editorial task to report a significantly increased rate of manuscript submissions to Homeopathy. The journal received as many articles in the first 8 months of 2020 as it typically does in a full year. A happy consequence is that the current issue has more pagination than its immediate predecessors. Another piece of cheerful news is that the journal's Impact Factor has reached 1.704, an increase of 16% from its previous year's value. Homeopathy research and its key journal are evidently in fine health. It is also good to announce that the journal's home-page of online articles includes a Virtual Special Issue (VSI) that pools together all our published papers on the topic of COVID-19; further content will be added to the VSI as new coronavirus-related papers attain publication.

For clinical case reporting, Homeopathy has been asking authors to use the Modified Naranjo Criteria for Homeopathy to assess the likelihood of a causal relationship between a homeopathic intervention and the patient's outcome. Dr. Chetna Lamba and co-authors have undertaken research of published case reports in homeopathy and have proposed improved wording for several criteria in the assessment tool, under the new acronym MONARCH.[2] A clinical case series and a case report, on urinary stones[3] and pituitary microadenoma[4] respectively, reflect the recent trend for increased numbers of submitted manuscripts in this category. Additional original research articles in the current issue come from the fields of in-vitro investigation,[5] isopathic preparation and standardisation,[6] tropical disease,[7] and veterinary homeopathy.[8] With the homeopathy profession's reliance on high-quality provings of its medicines, the journal also welcomes the article by Dr. Todd Hoover on updated guidelines for drug provings in the Homœopathic Pharmacopœia of the United States.[9]

Debate or Commentary articles have been given enhanced prominence in the journal in the past 2 to 3 years. Their contemporary appeal is provided in this issue by contributions about the human microbiome,[10] nanoparticle research,[11] and journal club presentations.[12] A Commentary by Dr. Emma Macías-Cortés and her colleagues[13] outlines the process that—despite their rightful efforts to avert it—led to the retraction of the published paper in PloS ONE that reported their clinical trial on individualised homeopathy for depression in menopausal women[14]; two of the authors' connected papers, which are published in Homeopathy,[15] [16] remain untarnished by retraction of the parent article.



Publication History

Publication Date:
02 November 2020 (online)

© 2020. Thieme. All rights reserved.

The Faculty of Homeopathy